Given that neuromyotonia and myokymia are hallmark features of PNH in CASPR2 autoimmunity, two key questions arise: (1) to what extent do CASPR2 antibodies contribute to the pathogenesis of these symptoms? This evidence concerns the gene CNTNAP2 and Myokymia.